China’s AI unicorns aim to reduce reliance on government surveillance business


By Coco FengYujie Xue

SenseTime and Megvii, the most valuable Chinese AI unicorns worth US$7.5bil and US$4bil respectively, were added to the US Entity List in October last year. In 2019, surveillance was the biggest single end-use for AI in China, accounting for 53.8% of all AI-powered applications. — SCMP

When Chinese AI unicorns SenseTime, Megvii and Yitu were sanctioned by the US in October last year, it looked like a major threat to the survival of their business.

Yet the supply chain impact of being added to Washington’s Entity List, which restricted their access to American products, has been less significant than originally feared. In fact, it was quickly overshadowed by the need to diversify a business model overly reliant on government orders for surveillance cameras in a market that has since become saturated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
SCMP , surveillance technology

Next In Tech News

Smartphone on your kid’s Christmas list? How to know when they’re ready.
A woman's Waymo rolled up with a stunning surprise: A man hiding in the trunk
A safety report card ranks AI company efforts to protect humanity
Bitcoin hoarding company Strategy remains in Nasdaq 100
Opinion: Everyone complains about 'AI slop,' but no one can define it
Google faces $129 million French asset freeze after Russian ruling, documents show
Netflix’s $72 billion Warner Bros deal faces skepticism over YouTube rivalry claim
Pakistan to allow Binance to explore 'tokenisation' of up to $2 billion of assets
Analysis-Musk's Mars mission adds risk to red-hot SpaceX IPO
Analysis-Oracle-Broadcom one-two punch hits AI trade, but investor optimism persists

Others Also Read